SC dismisses plea seeking CBI probe against 10 pharma cos for selling Remdesivir, Favipiravir without valid license
New Delhi: The Supreme Court on Monday dismissed a plea alleging use of drugs Remdesivir and Favipiravir, without approval, for treatment of Covid-19 and also seeking CBI probe against ten Indian pharmaceutical firms for selling these medicines allegedly in the absence of valid licenses. A bench, headed by Chief Justice of India D.Y. Chandrachud and […] More